Professor Stephen Ryder

Professor Stephen Ryder is a consultant Physician in Hepatology and Gastroenterology at BMI The Park Hospital and the Nottingham Digestive Diseases Centre and Biomedical Research Unit. He is also Co-Clinical Director for the East Midlands Cancer Network and Clinical Director of Research and Innovation at Nottingham University Hospitals NHS Trust.

His major clinical and research interests are viral hepatitis and alcohol related liver injury. He has published a number of studies on the investigation of abnormal liver blood tests and the early diagnosis of liver disease. He has also contributed to national and European guidelines for the treatment of hepatitis C. He was the main author of the national guidelines for the management of primary liver cancer.

Professor Ryder has always contributed to clinical research in liver disorders with the aim of ensuring patients have access to the latest technologies and treatments in liver disease. He was the national lead for the Hepatology Clinical Research Network and has had a significant role in coordinating clinical trials of new therapies for hepatitis C and ensuring as many people as possible from the UK with hepatitis C have access to trial therapies. Professor Ryder was past Hepatology Vice President of the British Society of Gastroenterology. He contributed to the Lancet Commission on liver disease- a group involving clinicians- patient groups and charities to help advance liver services for people living with liver disease in the UK. He is a trustee and medical advisor to The British Liver Trust, the main UK charity representing people with all forms of liver disorders.

Diseases, Medical Tests and Treatments

Investigation of abnormal liver function tests